Mavens Biotech (Delisted) share price history

BSE: 590083

Last traded ₹0.47 on 7 Mar 2017

Delisted on 6 Apr 2017.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements

Share price history

Daily closes since Aug 2008, adjusted for splits and bonuses. Earlier closes are left out: on 25 Aug 2008 the price changed in a way no corporate action on record explains.

Daily close, ₹ per share

Results

Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results

Quarter to Dec 2016, against the quarter before

Revenue
₹0.21 Crdown 40.58%
Net profit
₹0.01 Cr0.00%
Net margin
4.4%

Revenue by year

Peak revenue ₹56 Cr, year to Mar 2011

Net profit by year, a loss in red

₹ croreMar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016
Revenue0.400.210.210.23–0.210.350.21
Net profit0.010.040.030.05–0.010.010.01
Net margin3.3%18.5%11.8%22.7%–4.7%2.6%4.4%
Standalone. The last eight quarters. The latest is shaded. No results on record for the quarter to Mar 2016.

Where the return came from

Yearly rates to Mar 2015, per-share figures restated for splits and bonuses.

OverReturn a yearEarnings growthChange in P/EDividend yield
1 year+24.5%––0.0%
3 years−34.5%−43.6%+16.2%0.0%
5 years−58.3%––0.0%
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 3 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count. Earnings growth and the change in P/E over 1 and 5 years are left empty: the earnings per share stated for one end does not match that year's profit and share count, and no share count is on record to work it out.

Mavens Biotech share price by year

Each calendar year to 2017.

YearClose at year endChangeHighest closeLowest close
20170.47−19.0%0.690.45
20160.58−1.7%0.810.44
20150.59−22.4%0.900.51
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2017 close is its last trade, on 7 Mar 2017.

Recent sessions

The last 10 trading days to 7 Mar 2017, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
7 Mar 20170.470.470.470.470.47800
6 Mar 20170.490.500.490.490.497,181
3 Mar 20170.530.530.510.510.518,989
2 Mar 20170.550.550.530.530.5514,000
1 Mar 20170.570.570.550.550.567,250
28 Feb 20170.570.570.570.570.57600
27 Feb 20170.600.600.600.600.60100
23 Feb 20170.660.660.630.630.6519,517
20 Feb 20170.690.690.660.660.694,509
17 Feb 20170.670.690.640.690.6633,325
Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.

Ex-dateEventPrice factorWhat happened
16 Apr 2015Price move–Between two trading sessions the price moved by a fifth or more. The company made an announcement in time for trading that day or the trading day before. Not adjusted for.
25 Aug 2008Price move–Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown.
Where an event has no factor that can be worked out, the chart leaves out the closes before it. Any other event is noted and not adjusted for.

Company details

Legal name
MAVENS BIOTECH LTD.
BSE code
590083
ISIN
INE856C01047
Listed
May 2008
Face value
₹1
CIN
L17297WB1981PLC034226
Corporate identity number, the registrar of companies' code for it